BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 32586174)

  • 81. Effects of endometrial preparations and transferred embryo types on pregnancy outcome from patients with advanced maternal age.
    Liu J; Zheng J; Lei YL; Wen XF
    Syst Biol Reprod Med; 2019 Apr; 65(2):181-186. PubMed ID: 30091374
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Pituitary Suppression with Gonadotropin-Releasing Hormone Agonist Prior to Artificial Endometrial Preparation in Frozen-Thawed Embryo Transfer Cycles: A Systematic Review and Meta-Analysis of Different Protocols and Infertile Populations.
    Ho NT; Ho DKN; Tomai XH; Nguyen NN; Nguyen HS; Hu YM; Kao SH; Tzeng CR
    Biomedicines; 2024 Mar; 12(4):. PubMed ID: 38672116
    [TBL] [Abstract][Full Text] [Related]  

  • 83. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Long-term pituitary downregulation before frozen embryo transfer improves clinical outcomes in women positive for serum autoantibodies.
    Zhang Y; Xia M; Song Y; Wang J; Mao Y; Liu J; Ma X
    Eur J Obstet Gynecol Reprod Biol; 2021 Oct; 265():102-106. PubMed ID: 34482233
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Frozen blastocyst transfer outcomes in immediate versus delayed subsequent cycles following GnRH agonist or hCG triggers.
    Kaye L; Marsidi A; Rai P; Thorne J; Nulsen J; Engmann L; Benadiva C
    J Assist Reprod Genet; 2018 Apr; 35(4):669-675. PubMed ID: 29297113
    [TBL] [Abstract][Full Text] [Related]  

  • 86. The gonadotropin-releasing hormone antagonist protocol--the protocol of choice for the polycystic ovary syndrome patient undergoing controlled ovarian stimulation.
    Kol S; Homburg R; Alsbjerg B; Humaidan P
    Acta Obstet Gynecol Scand; 2012 Jun; 91(6):643-7. PubMed ID: 22428986
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Gonadotropin-releasing hormone agonist for ovulation trigger - OHSS prevention and use of modified luteal phase support for fresh embryo transfer.
    Castillo JC; Haahr T; Martínez-Moya M; Humaidan P
    Ups J Med Sci; 2020 May; 125(2):131-137. PubMed ID: 32366146
    [TBL] [Abstract][Full Text] [Related]  

  • 88. In-vitro fertilization and embryo transfer in patients with endometriosis: impact of a gonadotrophin releasing hormone agonist.
    Oehninger S; Brzyski RG; Muasher SJ; Acosta AA; Jones GS
    Hum Reprod; 1989 Jul; 4(5):541-4. PubMed ID: 2507576
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Outcome of Different Endometrial Preparation Protocols Prior to Frozen-Thawed Embryo Transfer on Pregnancy Outcomes in Women with Repeated Implantation Failure.
    Xiu YL; Sun KX; Zhang Q; Xiao YH; Bai X; Chen Y; Zhao MS; Yu YX
    Int J Womens Health; 2023; 15():1835-1844. PubMed ID: 38035202
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Long-term pituitary downregulation before frozen embryo transfer could improve pregnancy outcomes in women with adenomyosis.
    Niu Z; Chen Q; Sun Y; Feng Y
    Gynecol Endocrinol; 2013 Dec; 29(12):1026-30. PubMed ID: 24006906
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Dual trigger with gonadotropin releasing hormone agonist and human chorionic gonadotropin significantly improves live birth rate for women with diminished ovarian reserve.
    Lin MH; Wu FS; Hwu YM; Lee RK; Li RS; Li SH
    Reprod Biol Endocrinol; 2019 Jan; 17(1):7. PubMed ID: 30609935
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Effect of pretreatment with oral contraceptives and progestins on IVF outcomes in women with polycystic ovary syndrome.
    Wei D; Shi Y; Li J; Wang Z; Zhang L; Sun Y; Zhou H; Xu Y; Wu C; Liu L; Wu Q; Zhuang L; Du Y; Li W; Zhang H; Legro RS; Chen ZJ
    Hum Reprod; 2017 Feb; 32(2):354-361. PubMed ID: 27999118
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Comparative study on the pregnancy outcomes of in vitro fertilization-embryo transfer between long-acting gonadotropin-releasing hormone agonist combined with transvaginal ultrasound-guided cyst aspiration and long-acting gonadotropin-releasing hormone agonist alone.
    Guo YH; Lu N; Zhang Y; Su YC; Wang Y; Zhang YL; Sun YP
    Contemp Clin Trials; 2012 Nov; 33(6):1206-10. PubMed ID: 22820320
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The future of frozen-thawed embryo transfer in hormone replacement therapy cycles.
    Løssl K; Spangmose AL; Asserhøj LL; Dam TV; Pinborg A
    Curr Opin Obstet Gynecol; 2023 Jun; 35(3):200-209. PubMed ID: 37185352
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Euploidy rates between cycles triggered with gonadotropin-releasing hormone agonist and human chorionic gonadotropin.
    Thorne J; Loza A; Kaye L; Nulsen J; Benadiva C; Grow D; Engmann L
    Fertil Steril; 2019 Aug; 112(2):258-265. PubMed ID: 31103285
    [TBL] [Abstract][Full Text] [Related]  

  • 96. [Comparison of gonadotropin releasing hormone agonist long protocol and gonadotropin releasing hormone antagonist protocol in infertile women].
    Ren Y; Yang S; Yang R; Li R; Chen XN; Wang HY; Ma CH; Liu P; Qiao J
    Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Dec; 45(6):877-81. PubMed ID: 24343066
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Replacing single frozen-thawed euploid embryos in a natural cycle in ovulatory women may increase live birth rates compared to medicated cycles in anovulatory women.
    Melnick AP; Setton R; Stone LD; Pereira N; Xu K; Rosenwaks Z; Spandorfer SD
    J Assist Reprod Genet; 2017 Oct; 34(10):1325-1331. PubMed ID: 28647784
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Intranasal gonadotropin-releasing hormone agonist (GnRHa) for luteal-phase support following GnRHa triggering, a novel approach to avoid ovarian hyperstimulation syndrome in high responders.
    Bar-Hava I; Mizrachi Y; Karfunkel-Doron D; Omer Y; Sheena L; Carmon N; Ben-David G
    Fertil Steril; 2016 Aug; 106(2):330-3. PubMed ID: 27114332
    [TBL] [Abstract][Full Text] [Related]  

  • 99. [Effects of cetrorelix versus ganirelix in gonadotropin-releasing hormone antagonist cycles for preventing premature luteinizing hormone surges and on clinical outcomes of IVF-ET cycles].
    Zhang J; Zhou X; Chen Y; Zhang Q; Li Y; Zhe J; Chen X; Chen S
    Nan Fang Yi Ke Da Xue Xue Bao; 2019 Oct; 39(10):1207-1212. PubMed ID: 31801718
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Equivalent live-birth rate in antagonist IVF/ICSI protocol after oocyte triggering with GnRH agonist supplemented with 1500 r-hCG the day of oocyte retrieval vs r-hCG : A case-control study.
    Cherrière F; Arvis P; Le Pabic E; Bidet M; Jaffré F; Guivarc'h-Levêque A
    J Gynecol Obstet Hum Reprod; 2020 Jun; 49(6):101702. PubMed ID: 32018042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.